Active Substance/INN | Metotrexato |
---|---|
Dosage | 2 mg/ml |
Pharmaceutical Form | Oral solution |
Product Type |
Jylamvo (Metotrexato)
Pharmacotherapeutic Group: Oncology
Biojam Area: Biojam Pharma Portugal
Related products
Parkinson's disease
Rare Diseases
Oncology
Rare Diseases